Categories AlphaGraphs, Earnings, LATEST, Technology
Keysight Technologies tops Q3 estimates; lifts 2019 outlook
Keysight Technologies (NYSE: KEYS) rose about 7% in the extended hours as the company beat third quarter 2019 estimates and raised the fiscal 2019 outlook. GAAP revenue and non-GAAP revenue, both grew 8% to $1.087 billion and $1.088 billion, respectively. Non-GAAP EPS grew 41% to $1.25 in the third quarter ended July 31, 2019.
Analysts had projected the company to post earnings of $1.02 per share on revenue of $1.05 billion. Keysight shares ended up 2.11% at $89.14 today.
The Santa Rosa, California-based firm lifted its non-GAAP revenue outlook for fiscal 2019. The company now expects full-year non-GAAP revenue growth to be between 9% and 10% versus the previous growth guidance of 7% and 8%.
Keysight’s fourth quarter 2019 GAAP revenue is expected to be in the range of $1.078 billion to $1.098 billion and non-GAAP revenue is expected to be in the range of $1.080 billion to $1.100 billion. Non-GAAP EPS for Q4 is expected to be in the range of $1.14 to $1.20.
“Keysight delivered another excellent quarter with both revenue and earnings exceeding the high-end of our guidance. Record third quarter revenue was driven by growth across the majority of our end markets as we continued to capture a significant portion of the demand we see in the marketplace,” said CEO Ron Nersesian.
Non-GAAP revenue from Commercial Communications and Electronic Industrial Solutions end markets increased 23%, and 3%, respectively. However, non-GAAP revenue from Aerospace, Defense & Government and Ixia Solutions end markets registered a decline of 1% and 7%, respectively in the third quarter.
KEYS stock, which reached a 52-week high on July 1, had gained 43% so far this year and 47% in the trailing 12 months.
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was